Related Experiment Videos
[Intractable vasculitis: general consideration-concept and classification: pathological aspects]
1Department of Pathology, Shinshu University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1994
Summary
Vasculitis is vascular wall inflammation. Classification by vessel size aids understanding, and while often intractable, early treatment of systemic necrotizing vasculitides improves prognosis.
Area of Science:
- Rheumatology and Immunology: Focuses on inflammatory processes affecting the vascular system.
- Pathology: Examines the structural changes within blood vessel walls.
- Internal Medicine: Addresses systemic inflammatory disorders impacting multiple organs.
Context:
- Vasculitis involves inflammation of the vascular wall, potentially leading to secondary circulatory issues and nonspecific symptoms.
- Etiology remains unclear for many vasculitides, complicating classification despite understanding pathogenesis.
- Lesions can be widespread in systemic syndromes or affect long segments in large artery arteritides.
Purpose:
- To define vasculitis and outline its pathological and clinical characteristics.
- To discuss the challenges in classifying vasculitis due to unknown etiologies.
- To present a vessel-size-based classification for understanding clinical manifestations.
Summary:
- Vasculitis classification is proposed based on predominant vessel size: large arteries, medium/small muscular arteries, and small vessels (arterioles/venules).
- While primary idiopathic vasculitides often have a poor prognosis, advances in drug therapy for conditions like Wegener's granulomatosis have improved outcomes.
- Takayasu's arteritis management has extended patient survival, though complications like stenosis or dilatation persist.
Impact:
- Provides a framework for understanding and diagnosing diverse vasculitic disorders.
- Highlights the importance of early intervention and advances in therapeutic strategies.
- Improves patient outcomes and quality of life through better disease management.